Skip to main content
NCBI home page
Heart logoLink to Heart
. 1996 Oct;76(4):363–366. doi: 10.1136/hrt.76.4.363

Pulmonary balloon valvuloplasty in the palliation of complex cyanotic congenital heart disease.

O Stümper 1, J F Piéchaud 1, P Bonhoeffer 1, D Bonnet 1, Y Aggoun 1, D Sidi 1, J Kachaner 1
PMCID: PMC484551  PMID: 8983686

Abstract

OBJECTIVE: To assess the value of pulmonary balloon valvuloplasty in the interim palliation of complex congenital heart disease and pulmonary stenosis in children, who often require numerous palliative operations before definitive surgical repair. METHODS: Evaluation of pulmonary balloon valvuloplasty procedures performed over a five year period in 18 patients (age 8 days--29 years; mean 5.5 years) with complex cyanotic congenital heart disease. RESULTS: After pulmonary balloon valvuloplasty oxygen saturation increased from a mean (SD) of 69 (7.5)% to 83 (7.0)% (P < 0.001). Mean pulmonary artery pressure increased from a mean (SD) of 11.3 (3.8) mm Hg to 15.7 (3.9) mm Hg (P < 0.001). Transient complete atrioventricular block occurred in one patient. No other complications were encountered. In 5 patients (28%) there was an inadequate improvement in cyanosis compared with pre-procedure values (72 (4.7)% v 66 (8.1)%). Reasons for failure were increasing infundibular stenosis in three and inadequate mixing in one child. In 13 patients (72%) pulmonary balloon valvuloplasty gave adequate interim palliation over a mean follow up of 1.1 (1.3) years. Oxygen saturation was 81 (5.6)% at last follow up compared with 70 (7.3)% before pulmonary balloon valvuloplasty (P < 0.001). CONCLUSION: Pulmonary balloon valvuloplasty is a safe and effective technique in the palliation of patients with complex cyanotic congenital heart disease associated with pulmonary valve stenosis.

Full text

PDF
363

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boucek M. M., Webster H. E., Orsmond G. S., Ruttenberg H. D. Balloon pulmonary valvotomy: palliation for cyanotic heart disease. Am Heart J. 1988 Feb;115(2):318–322. doi: 10.1016/0002-8703(88)90477-2. [DOI] [PubMed] [Google Scholar]
  2. Kan J. S., White R. I., Jr, Mitchell S. E., Gardner T. J. Percutaneous balloon valvuloplasty: a new method for treating congenital pulmonary-valve stenosis. N Engl J Med. 1982 Aug 26;307(9):540–542. doi: 10.1056/NEJM198208263070907. [DOI] [PubMed] [Google Scholar]
  3. Kay P. H., Capuani A., Franks R., Lincoln C. Experience with the modified Blalock-Taussig operation using polytetrafluoroethylene (Impra) grafts. Br Heart J. 1983 Apr;49(4):359–363. doi: 10.1136/hrt.49.4.359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lenfant C. Enhancing minority participation in research. The NHLBI experience. Circulation. 1995 Aug 1;92(3):279–280. doi: 10.1161/01.cir.92.3.279. [DOI] [PubMed] [Google Scholar]
  5. McCrindle B. W. Independent predictors of long-term results after balloon pulmonary valvuloplasty. Valvuloplasty and Angioplasty of Congenital Anomalies (VACA) Registry Investigators. Circulation. 1994 Apr;89(4):1751–1759. doi: 10.1161/01.cir.89.4.1751. [DOI] [PubMed] [Google Scholar]
  6. Piéchaud J. F., Delogu A. B., Iserin L., Aggoun Y., Cohen L., Sidi D., Kachaner J. Traitement palliatif de la tétralogie de Fallot par dilatation infundibulo-pulmonaire percutanée. Etude de 40 cas. Arch Mal Coeur Vaiss. 1994 May;87(5):573–579. [PubMed] [Google Scholar]
  7. Qureshi S. A., Kirk C. R., Lamb R. K., Arnold R., Wilkinson J. L. Balloon dilatation of the pulmonary valve in the first year of life in patients with tetralogy of Fallot: a preliminary study. Br Heart J. 1988 Sep;60(3):232–235. doi: 10.1136/hrt.60.3.232. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Rey C., Marache P., Francart C., Dupuis C. Percutaneous transluminal balloon valvuloplasty of congenital pulmonary valve stenosis, with a special report on infants and neonates. J Am Coll Cardiol. 1988 Apr;11(4):815–820. doi: 10.1016/0735-1097(88)90216-1. [DOI] [PubMed] [Google Scholar]
  9. Sluysmans T., Neven B., Rubay J., Lintermans J., Ovaert C., Mucumbitsi J., Shango P., Stijns M., Vliers A. Early balloon dilatation of the pulmonary valve in infants with tetralogy of Fallot. Risks and benefits. Circulation. 1995 Mar 1;91(5):1506–1511. doi: 10.1161/01.cir.91.5.1506. [DOI] [PubMed] [Google Scholar]
  10. Stavri G. T., Zachary I. C., Baskerville P. A., Martin J. F., Erusalimsky J. D. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation. 1995 Jul 1;92(1):11–14. doi: 10.1161/01.cir.92.1.11. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES